Claro Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Sell
494
-4
-0.8% -$2.24K 0.03% 444
2026
Q1
$280K Hold
498
0.03% 394
2025
Q4
$337K Buy
498
+4
+0.8% +$2.72K 0.05% 308
2025
Q3
$316K Hold
494
0.05% 304
2025
Q2
$265K Sell
494
-194
-28% -$92.8K 0.04% 318
2025
Q1
$289K Buy
688
+52
+8% +$22.6K 0.04% 391
2024
Q4
$263K Sell
636
-9,144
-93% -$4.01M 0.04% 391
2024
Q3
$4.94M Sell
9,780
-434
-4% -$211K 0.64% 28
2024
Q2
$4.98M Sell
10,214
-2,844
-22% -$1.43M 0.78% 27
2024
Q1
$7.05M Sell
13,058
-905
-6% -$495K 1.22% 13
2023
Q4
$7.75M Sell
13,963
-319
-2% -$150K 1.68% 8
2023
Q3
$6.25M Sell
14,282
-107
-0.7% -$53.4K 1.56% 8
2023
Q2
$7.23M Buy
14,389
+11,691
+433% +$5.6M 1.8% 7
2023
Q1
$1.35M Buy
2,698
+200
+8% +$95.7K 0.4% 56
2022
Q4
$1.02M Buy
+2,498
New +$970K 0.33% 78
2022
Q2
Sell
-699
Closed -$460K 303
2022
Q1
$460K Hold
699
0.17% 147
2021
Q4
$460K Buy
699
+2
+0.3% +$1.26K 0.17% 147
2021
Q3
$433K Sell
697
-57
-8% -$38.3K 0.18% 144
2021
Q2
$476K Buy
754
+4
+0.5% +$2.21K 0.21% 132
2021
Q1
$367K Buy
750
+12
+2% +$6.01K 0.19% 141
2020
Q4
$369K Buy
738
+5
+0.7% +$2.24K 0.2% 138
2020
Q3
$288K Sell
733
-13
-2% -$4.81K 0.18% 142
2020
Q2
$246K Buy
+746
New +$216K 0.17% 150
2019
Q1
Sell
-39
Closed -$10K 518
2018
Q4
$10K Buy
+39
New +$8K 0.01% 675

Other funds holding IDXX

Claro Advisors's IDXX Position: Q2 2026 in Review

Claro Advisors reduced its Idexx Laboratories (IDXX) stake by 0.8% in Q2 2026, selling an estimated $2.24K and leaving 494 shares worth $260K. The position accounts for 0.03% of the portfolio, ranked #444.

Claro Advisors first reported a position in IDXX in Q4 2018 and has held it in 24 quarters since. The position peaked at $7.75M in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Claro Advisors held 494 shares of Idexx Laboratories worth $260K as of Q2 2026.
  • Claro Advisors sold 4 Idexx Laboratories shares in Q2 2026, an estimated $2.24K.
  • Idexx Laboratories made up 0.03% of Claro Advisors's portfolio in Q2 2026, its #444 holding.
  • Claro Advisors first reported a position in Idexx Laboratories in Q4 2018 and has held it in 24 quarters since.
  • Claro Advisors's Idexx Laboratories position peaked at $7.75M in Q4 2023.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Claro Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.